logo

For the Inventor, By the Inventor

Mino, Japan

Hitoshi Nakamura

This inventor holds 8 USPTO granted patents. Top assignee: Fujisawa Pharmaceutical Company, Ltd.. Active years: 1976-1996.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hitoshi Nakamura. Retrieved from https://idiyas.com/inventor/hitoshi-nakamura-kz589rdk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 100.0

Average Co-Inventor Count = 5.6

ph-index = 4

Forward Citations = 66(Granted Patents)


Location History:

  • Toyonaka, JA (1976 - 1978)
  • Toyonaka, JP (1981 - 1990)
  • Mino, JP (1990 - 1996)

Company Filing History:

goldMedal8 out of 940 
 
Fujisawa Pharmaceutical Company, Ltd.
 patents

Years Active: 1976-1996

Loading Chart...
8 patents (USPTO):Explore Patents
1. 5525722 - Process for producing biocozamycin benzoate (1996-06-11),
2. 4935507 - Crystalline (1990-06-19),
3. 4931555 - Disulfide substituted oxazetidine derivatives (1990-06-05),
4. 4267340 - Disulfide substituted oxazetidine derivatives (1981-05-12),
5. 4071527 - Certain benzothiazole compounds (1978-01-31),
6. 4036847 - Halogenated penam derivatives and the preparation thereof (1977-07-19),
7. 4009159 - Halogenated penam derivatives and the preparation thereof (1977-02-22),
8. 3993646 - Process for the ring expansion of penicillins to cephalosporin compounds (1976-11-23),

Title: Hitoshi Nakamura: Innovator in Antimicrobial Agents

Introduction

Hitoshi Nakamura is a prominent inventor based in Mino, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of antimicrobial agents. With a total of 8 patents to his name, Nakamura's work has had a notable impact on medical science.

Latest Patents

One of his latest patents is titled "Process for producing biocozamycin benzoate - Crystalline." This invention relates to crystalline 7-[2-(2-aminothiazol-4-yl)-2-hydroxyiminoacetamido]-3-vinyl-3-cephem-4-carboxylic acid (syn isomer), which is useful as an antimicrobial agent. This innovative approach showcases his commitment to advancing healthcare solutions.

Career Highlights

Nakamura is currently employed at Fujisawa Pharmaceutical Company, Ltd., where he continues to push the boundaries of pharmaceutical research. His work at this esteemed company has allowed him to collaborate with other talented professionals in the field.

Collaborations

Some of his notable coworkers include Takashi Kamiya and Yoshihisa Saito. Their combined expertise contributes to the innovative environment at Fujisawa Pharmaceutical Company, Ltd.

Conclusion

Hitoshi Nakamura's contributions to the field of antimicrobial agents through his patents and collaborations highlight his role as a key innovator in the pharmaceutical industry. His work continues to inspire advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…